Convergence Investment Partners’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-4,909
| Closed | -$420K | – | 324 |
|
|
2018
Q3 | $420K | Sell |
4,909
-6,880
| -58% | -$589K | 0.09% | 237 |
|
|
2018
Q2 | $1.37M | Sell |
11,789
-8,479
| -42% | -$982K | 0.19% | 153 |
|
|
2018
Q1 | $1.64M | Buy |
+20,268
| New | +$1.64M | 0.21% | 166 |
|
|
2016
Q2 | – | Sell |
-18,148
| Closed | -$533K | – | 326 |
|
|
2016
Q1 | $533K | Buy |
+18,148
| New | +$533K | 0.06% | 293 |
|
|
2015
Q3 | – | Sell |
-51,840
| Closed | -$2.33M | – | 361 |
|
|
2015
Q2 | $2.33M | Buy |
+51,840
| New | +$2.33M | 0.23% | 146 |
|
|
2014
Q4 | – | Sell |
-53,130
| Closed | -$2.1M | – | 381 |
|
|
2014
Q3 | $2.1M | Buy |
+53,130
| New | +$2.1M | 0.29% | 134 |
|